PT101182A - Antagonistas de ltb4 a base de benzopiranos e relacionados, e processo para a sua preparacao - Google Patents

Antagonistas de ltb4 a base de benzopiranos e relacionados, e processo para a sua preparacao

Info

Publication number
PT101182A
PT101182A PT101182A PT10118293A PT101182A PT 101182 A PT101182 A PT 101182A PT 101182 A PT101182 A PT 101182A PT 10118293 A PT10118293 A PT 10118293A PT 101182 A PT101182 A PT 101182A
Authority
PT
Portugal
Prior art keywords
benzopiranes
preparation
ltb4 antagonists
antagonists based
ltb4
Prior art date
Application number
PT101182A
Other languages
English (en)
Inventor
Lawrence Sherman Melvin Jr
Lawrence Alan Reiter
Kevin Koch
Sally G Ruggeri
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PT101182A publication Critical patent/PT101182A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/08Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing alicyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/11Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same saturated acyclic carbon skeleton
    • C07C255/13Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same saturated acyclic carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
PT101182A 1992-01-23 1993-01-22 Antagonistas de ltb4 a base de benzopiranos e relacionados, e processo para a sua preparacao PT101182A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82467892A 1992-01-23 1992-01-23
US89005592A 1992-05-28 1992-05-28

Publications (1)

Publication Number Publication Date
PT101182A true PT101182A (pt) 1994-03-31

Family

ID=27124835

Family Applications (1)

Application Number Title Priority Date Filing Date
PT101182A PT101182A (pt) 1992-01-23 1993-01-22 Antagonistas de ltb4 a base de benzopiranos e relacionados, e processo para a sua preparacao

Country Status (27)

Country Link
US (1) US5550152A (pt)
EP (1) EP0623122B1 (pt)
JP (1) JP2813464B2 (pt)
KR (1) KR950700274A (pt)
CN (1) CN1074681A (pt)
AP (1) AP385A (pt)
AT (1) ATE149493T1 (pt)
AU (1) AU2773392A (pt)
BG (1) BG98873A (pt)
BR (1) BR9207064A (pt)
CA (1) CA2117349C (pt)
CZ (1) CZ395492A3 (pt)
DE (1) DE69217998T2 (pt)
DK (1) DK0623122T3 (pt)
ES (1) ES2098547T3 (pt)
FI (1) FI943473A (pt)
GR (1) GR3022999T3 (pt)
HU (1) HUT67929A (pt)
IL (1) IL104421A0 (pt)
IS (1) IS3968A (pt)
MX (1) MX9300313A (pt)
NO (1) NO942758D0 (pt)
OA (1) OA10713A (pt)
PT (1) PT101182A (pt)
TW (1) TW213456B (pt)
UY (1) UY23537A1 (pt)
WO (1) WO1993015066A1 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9300312A (es) * 1992-01-23 1993-07-31 Pfizer Antagonistas benzopiranicos y relacionado de ltb.
KR100232341B1 (ko) * 1994-10-13 2000-07-01 디. 제이. 우드 류코트리엔 b4(ltb4) 길항물질로서의 벤조피란 및 벤조-축합된 화합물
MX9702734A (es) * 1994-10-13 1997-06-28 Pfizer Benzopirano y compuestos benzocondensados, su preparacion y su uso como antagonistas de leucotrieno b4 (ltb4).
KR100339164B1 (ko) * 1996-09-16 2002-06-01 디. 제이. 우드, 스피겔 알렌 제이 치환된 크로만올 유도체의 제조 방법 및 이에 사용되는 중간체
US6416733B1 (en) 1996-10-07 2002-07-09 Bristol-Myers Squibb Pharma Company Radiopharmaceuticals for imaging infection and inflammation
EP0836850A3 (en) * 1996-10-17 2000-11-29 Pfizer Inc. Method of preventing allograft rejection
EP0963755A3 (en) * 1998-04-16 2001-03-14 Pfizer Products Inc. Use of benzopyranes for preventing allograft rejection
HUP0400758A3 (en) 2000-11-03 2005-02-28 Bristol Myers Squibb Pharma Co Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation
US6541613B2 (en) * 2000-12-15 2003-04-01 Uyrex Corporation Isoflavone derivatives
US6958156B2 (en) * 2000-12-15 2005-10-25 Vyrex Corporation Isoflavone derivatives
MXPA03006876A (es) * 2001-01-30 2003-11-13 Pfizer Prod Inc Intermedios y procedimientos para preparar derivados de cromanol sustituido.
US20080260817A1 (en) * 2004-07-22 2008-10-23 Phenil Jayantilal Patel Compositions for the Treatment of Inflammation and Pain Using a Combination of a Cox-2 Selective Inhibitor and a Ltb4 Receptor Antagonist
PT2089367E (pt) * 2006-10-31 2012-02-01 Pfizer Prod Inc Compostos de pirazolina como antagonistas dos receptores mineralcorticóides
CN104710438B (zh) * 2013-12-11 2019-11-29 中国科学院上海药物研究所 促进iPS细胞产生的螺环类化合物及其制备方法和用途
JP6590224B2 (ja) * 2014-11-11 2019-10-16 学校法人順天堂 加齢黄斑変性症予防又は治療剤
TW201711999A (zh) 2015-09-03 2017-04-01 佛瑪治療公司 ﹝6,6﹞稠合雙環組蛋白脫乙醯基酶8(hdac8)抑制劑
EP3383868B1 (en) 2015-11-30 2022-10-05 Merck Sharp & Dohme LLC Aryl sulfonamides as blt1 antagonists
WO2017095725A1 (en) 2015-11-30 2017-06-08 Merck Sharp & Dohme Corp. Aryl sulfonamides as blt1 antagonists
US10370368B2 (en) 2015-11-30 2019-08-06 Merck Sharp & Dohme Corp. Aryl acylsulfonamides as BLT1 antagonists
EP3383388B1 (en) 2015-11-30 2021-04-14 Merck Sharp & Dohme Corp. Aryl acylsulfonamides as blt1 antagonists
CN109289091B (zh) * 2018-10-09 2021-04-13 温州医科大学附属第一医院 一种用于装载骨髓间充质干细胞的复合支架及其制备方法
CN111647003B (zh) * 2020-06-08 2022-06-21 中国科学院昆明植物研究所 三环氧六氢色酮a及其药物组合物和其应用
CN111671745A (zh) * 2020-07-29 2020-09-18 北京大学 化合物在治疗溃疡性结肠炎药物制备中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4565882A (en) * 1984-01-06 1986-01-21 G. D. Searle & Co. Substituted dihydrobenzopyran-2-carboxylates
CA1320490C (en) * 1987-01-12 1993-07-20 Darrel M. Gapinski Anti-inflammatory agents
US4889871A (en) * 1987-05-29 1989-12-26 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives
US5059609A (en) * 1987-10-19 1991-10-22 Pfizer Inc. Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
WO1990015801A1 (en) * 1989-06-22 1990-12-27 Pfizer Inc. Substituted sulfonamides and related compounds in the treatment of asthma, arthritis and related diseases

Also Published As

Publication number Publication date
FI943473A0 (fi) 1994-07-22
AP385A (en) 1995-05-15
OA10713A (en) 2002-12-04
NO942758L (no) 1994-07-22
US5550152A (en) 1996-08-27
AP9200441A0 (en) 1993-01-31
ATE149493T1 (de) 1997-03-15
DE69217998T2 (de) 1997-06-12
WO1993015066A1 (en) 1993-08-05
NO942758D0 (no) 1994-07-22
IS3968A (is) 1993-07-24
BR9207064A (pt) 1995-12-19
EP0623122A1 (en) 1994-11-09
JPH07503464A (ja) 1995-04-13
IL104421A0 (en) 1993-05-13
FI943473A (fi) 1994-07-22
BG98873A (en) 1995-03-31
CN1074681A (zh) 1993-07-28
CA2117349A1 (en) 1993-08-05
DE69217998D1 (de) 1997-04-10
ES2098547T3 (es) 1997-05-01
JP2813464B2 (ja) 1998-10-22
GR3022999T3 (en) 1997-07-30
HUT67929A (en) 1995-05-29
KR950700274A (ko) 1995-01-16
TW213456B (pt) 1993-09-21
UY23537A1 (es) 1993-06-28
CA2117349C (en) 2000-02-29
AU2773392A (en) 1993-09-01
HU9402163D0 (en) 1994-09-28
CZ395492A3 (en) 1994-03-16
EP0623122B1 (en) 1997-03-05
MX9300313A (es) 1994-06-30
DK0623122T3 (da) 1997-04-21

Similar Documents

Publication Publication Date Title
PT101182A (pt) Antagonistas de ltb4 a base de benzopiranos e relacionados, e processo para a sua preparacao
BR9002288A (pt) Copolimeros hidrossoluveis,processo para a sua obtencao e sua utilizacao
PT909327E (pt) Eritromicinas e processo para a sua preparacao
PT799866E (pt) Negro-de-fumo e processo para a sua preparacao
BR9600148A (pt) Quinazolinonas 2,8-dissubstituídas processo para sua preparação medicamentos e uso
BR9402516A (pt) Silanos, processo para a sua fabricação e sua utilização
PT799052E (pt) Nova formulacao antitrombotica, processo para a sua preparacao e sua utilizacao
PT100900A (pt) Processo para a preparacao de peptidos conjugados, e peptidos assim obtidos
PT100993A (pt) Heterociclos susbstituidos, nomeadamente derivados de quinazolina, processo para a sua preparacao e sua utilizacao
PT750907E (pt) Formulacoes de vacinas estaveis para administracao parenterica metodo para a sua utilizacao e processo para a sua preparacao
BR9000116A (pt) Alfa-diazo-beta-cetoester polifuncional,processo para sua preparacao e sua utilizacao
BR9402424A (pt) Compostos apresentando grupos amino terciário, processo para a sua preparação e sua utilização
BR9408219A (pt) Comprimidos de paroxetina e um processo para a sua preparação
BR9503512A (pt) Composto organometálico e processo para a sua preparaçao
PT100316A (pt) Anticoagulantes e processo para a sua preparacao
PT101183A (pt) Antagonistas de ltb4 a base de benzopirano e afins e processo para a sua preparacao
BR9501980A (pt) Copolimeros,processo para sua preparação
BR9401212A (pt) Catalisador de hidrogenação, processo para a sua preparação e seu emprego
BR9600147A (pt) Purin-6-onas 2,9-DI-substituidas processo para sua preparação medicamentos e uso
BR9202325A (pt) Composto,processo para a sua preparacao,preparado farmaceutico e processo para a sua preparacao
BR9200244A (pt) Pre-polimeros de isocianato,processo para a sua preparacao e sua aplicacao
BR8904062A (pt) Catalisadores,processo para a sua preparacao e aplicacao
BR9303456A (pt) Compostos,processo para sua preparacao,medicamentos,processo para sua preparacao e emprego
BR9004194A (pt) Poliisocianatos,misturas,processo para sua preparacao e emprego
BR8801955A (pt) Poliaminas aromaticas,um processo para sua preparacao e aplicacao

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19930818

FC3A Refusal

Effective date: 19990504